Category: Intellectual property
-
U.S., Europe Agree on Patent Classification Principles
The U.S. and European patent authorities have agreed on the principles for a new system of classifying patents in their respective jurisdictions. A common classification system is expected to make it easier to search for patents across national boundaries. The United States Patent Trademark Office (USPTO) and European Patent Office (EPO) agreed that the new…
-
USPTO Gives Details of New Expedited Review Process
The U.S. Patent and Trademark Office (USPTO) released more details of its program that lets patent applicants choose the speed at which their application is processed. The program consists of three tracks, with higher fees charged for faster patent processing. USPTO plans to publish tomorrow (4 February) in the Federal Register a notice of the…
-
Endo Pharma, Orion Corp. to Advance Cancer Drugs
Endo Pharmaceuticals in Chadds Ford, Pennsylvania and Orion Corporation in Espoo, Finland said today they have a collaboration agreement for drug research and development in oncology. The partnership aims to advance eight discovery-phase cancer drug candidates by combining their relevant R&D programs. The collaboration also gives each company exclusive licensing rights to the other’s development-ready…
-
Patent Granted for Lung Disorder Treatment
Discovery Laboratories Inc., a biotechnology company in Warrington, Pennsylvania, said today the company received a U.S. patent for its treatment of pulmonary inflammation. The patent — number 7,863,241 — expires in 2023. Discovery Labs says the patent covers its KL4 peptide (also known as sinapultide), an engineered pulmonary surfactant that lowers surface tension and promote…
-
University, Start Up Develop Anti-Counterfeit Technology
A student at Simon Fraser University (SFU) in Burnaby, British Columbia, Canada researched a new method based on nanotechnology for stopping counterfeiters, which has led to the founding of a new company to develop the product. Nanotechnology uses materials at nanometer scale, with one nanometer equal to one billionth of a meter. Clint Landrock, an…
-
Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test
Opko Health Inc., a biotechnology company in Miami, Florida, said today it has a collaboration agreement with the drug manufacturer Bristol-Myers Squibb Company for Opko’s diagnostic test technology. Opko’s blood tests are being developed from its technology that identifies biomarkers for a range of diseases including neurodegenerative disorders. Part of the project calls for Opko…
-
Univ. Engineers Develop New Sewage Treatment Device
Research engineers at University of Utah in Salt Lake City have developed and commercialized an alternative device to help growing communities deal with sewage treatment. The device, known as Poo-Gloos because of their igloo-like shape (pictured right), supplement wastewater lagoons often used for sewage treatment, particularly in small, rural towns. Kraig Johnson and research colleagues…
-
Spirogen, Genentech Partner on Anti-Cancer Therapies
Spirogen Ltd. a London, U.K. biotechnology company, announced a multi-year research collaboration and license agreement with Genentech, a Roche Group company, to discover and develop antibody drug conjugates (ADCs) as potential anti-cancer agents. The collaboration will make use of Spirogen’s pyrrolobenzodiazepine (PBD) drugs, a group of natural antibiotics, and associated linking technology. Under the agreement,…
-
Study: Longer Drug Exclusivity Hikes Costs, Adds Approvals
A new study in the January 2011 issue of the journal Health Affairs (paid subscription required) calculates the financial and social costs of regulations that limit access to pharmaceutical companies’ clinical trial data, used in the manufacture of generic drugs. The study suggests that extending the term of exclusive access for that data would likely…
-
National Lab Signs Two Auto Battery Licensing Deals
Argonne National Laboratory in Argonne, Illinois, part of the U.S. Department of Energy, announced two licensing agreements today (6 January 2011) for its cathode material technology used in electric vehicle lithium-ion (Li-ion) batteries. The deals are with or involve cars made by General Motors. The first agreement, with General Motors, involves the worldwide licensing of…